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Abstract The structural similarity of lysosphingolipids to 
lysophosphatidic acid (LPA) prompted a sequence-based search 
for lysosphingolipid receptors using cDNA sequence of the Edg2 
human LPA receptor. Two closely related G protein-coupled 
receptors, rat H218 and human Edg3, are highly similar to Edg2. 
When overexpressed in Jurkat cells, H218 and Edg3 activated 
serum response element-driven transcriptional reporter gene in 
response to sphingosine 1-phosphate (SIP), dihydro-SIP and 
sphingosylphosphorylcholine, but not to LPA. H218 and Edg3 
expressed in Xenopus oocytes conferred responsiveness to S I P 
and dihydro-SIP in agonist-triggered 4 5 Ca 2 + efflux. Therefore, 
H218 and Edg3 are functional receptors for S I P and perhaps 
other closely related lysosphingolipids. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Several types of sphingolipids regulate cell growth, differ-
entiation and programmed cell death as intracellular and ex-
tracellular messengers [1-3]. The lysosphingolipids, sphingo-
sine 1-phosphate (SIP) and sphingosylphosphorylcholine 
(SPC), are potent mediators of fibroblast mitogenesis [4-6], 
platelet activation [7] and neurite retraction [8]. The biochem-
ical signaling events elicited by S IP and SPC include intra-
cellular Ca 2 + mobilization [4,7,9-13], and activation of 4(Ach) 
[12,14] and M A P kinases [15]. Potential roles for lysosphingo-
lipids in cellular growth and survival are also implied by their 
ability to oppose the effects of ceramide on cell proliferation 
and apoptosis [16,17]. 
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Early findings suggested that S IP was principally an intra-
cellular second messenger mediating the proliferative effects of 
platelet-derived growth factor and evoking release of Ca 2 + 
from internal stores by an inositol 1,4,5-trisphosphate (IP3)-
independent mechanism [18-20]. Recent studies showed that 
some signaling responses to S IP and SPC were blocked by 
pertussis toxin, suggesting that S IP and SPC might act via cell 
surface G protein-coupled receptors (GPCRs) [3,5,7,8,10-15]. 
A similar dependence on G proteins has been observed for 
responses to lysophosphatidic acid (LPA), which is structur-
ally related to S I P and SPC. Two different G P C R s for LPA 
have recently been cloned and characterized by others and our 
laboratory [21-23]. However, the putative G P C R s for S IP 
and SPC have not been characterized at a molecular level. 
We selected three orphan G P C R s with amino acid sequen-
ces highly related to that of the Edg2 LPA receptor to exam-
ine their ability to confer responsiveness to lysosphingolipids. 
Expression of the G P C R s H218 and Edg3, but not E d g l , 
conferred activation of an SRE-driven transcriptional reporter 
gene in Jurkat T cells and 4 5 Ca 2 + efflux in Xenopus oocytes in 
response to S I P and related lysosphingolipids. 
2. Materials and methods 
2.1. Materials 
Sphingosine 1-phosphate (SIP), sphingosylphosphorylcholine 
(SPC), sphingosine (SP), dihydro-sphingosine 1-phosphate (dh-SIP), 
dihydro-sphingosine (dh-SP) and C6 ceramide (C6) were obtained 
from Biomol (Plymouth, PA). 1-Oleoyl-lysophosphatidic acid 
(LPA), 1-p-D-galactosylsphingosine (psychosine, PS), fatty acid-free 
human serum albumin (HSA) and bovine serum albumin (BSA) 
were purchased from Sigma (St. Louis, MO). The mammalian expres-
sion vectors pCDEF3 and pRC/CMV were obtained from Dr. Jerome 
Langer (UMD-New Jersey) and Invitrogen (La Jolla, CA), respec-
tively. DNA polymerase pfu and PCRScript vector were from Stra-
tagene (La Jolla, CA). DMRIE-C lipofection reagent for transfection 
and OPTI-MEM medium were from Gibco-BRL (Gaithersburg, 
MD). Jurkat leukemic T cells were obtained from Dr. Arthur Weiss 
(UCSF). Cell culture media and fetal bovine serum (FBS) were from 
UCSF Cell Culture Facilities. Plasmid pGL3-basic and luciferase as-
say reagents were from Promega (Madison, WI). 
2.2. Cloning and plasmid constructs 
The GenBank database was searched for sequences homologous to 
human Edg2 LPA receptor [23]. The recently recognized new subtype 
of human LPA receptor termed Edg4 [24] is the most homologous to 
Edg2 with 46% identity in amino acid sequence. The three 'orphan' 
GPCRs, human Edgl [25], rat H218 [26] and human Edg3 (GenBank 
accession number X83864), are less homologous with 31-34% identity. 
The cDNAs encoding the open reading frames of these three 'orphan' 
GPCRs were amplified with pfu polymerase by RT-PCR using RNAs 
isolated from human lung, rat brain and human fetal brain, respec-
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 1 3 0 1 - X 
280 S. An et allFEBS Letters 417 (1997) 279-282 
tively. The primers used for PCR amplifications were 5'-GCT-
TCCTGGGGACACAGGGTTGGCACCATG and 5'-ACACTGG-
GGTGGCAGCGACCACCAAGT for edgl, 5'-GGCCAAGCTT-
GTGCTCAGTCCCATG and 5'-GCTGTCCCTCTAGACCCTTA-
ATGGT for h218, 5'-TGTGAATTCCAAGTGATGGCAACTG 
and 5'-CGCATCTAGACGATCAGTTGCAGAAGATCCCATT for 
edg3. The amplified products were subcloned into expression vectors 
pCDEF3 (expression constructs designated Edgl/EF3, H218/EF3 and 
Edg3/EF3) and pRC/CMV (Edgl/CMV, H218/CMV and Edg3/ 
CMV). The sequences of these expression plasmids were confirmed 
using an ABI automated DNA sequencer (HHMI DNA core facility, 
UCSF). The construction of a serum response element (SRE) lucifer-
ase reporter gene plasmid containing four copies of SRE (5'-AG-
GATGTCCATATTAGGACATCT) and a TATA box has been pre-
viously described [23,27]. 
2.3. Reporter gene assay 
1X 107 Jurkat T cells were co-transfected with 0.2 ug SRE reporter 
gene plasmid and 2 ug of either empty pCDEF3 vector, H218/EF3 or 
Edg3/EF3 using DMRIE-C reagent. After 4 h of transfection incuba-
tion in OPTI-MEM containing 10% FBS, cells were washed and 
starved in serum-free RPMI 1640 at 37°C for 8 h. Cells were then 
washed, resuspended in serum-free RPMI 1640 and transferred in 0.15 
ml aliquots into 96-well plates. Various lipids to be tested were dis-
solved in serum-free RPMI 1640 containing 0.1 mg/ml of HSA and 
added to the cells followed by a 10 h incubation at 37°C. Cells were 
then disrupted by Reporter Lysis Buffer (Promega), and luciferase 
activities were measured using a Turner Designs 20/20 luminometer. 
2.4. Oocyte expression and i5Ca2+ efflux assay 
Templates for in vitro transcription were prepared by linearizing 
Edgl/CMV, H218/CMV and Edg3/CMV with Xbal. 7-Methylguano-
sine-capped transcripts were synthesized using the mMESSAGE 
mMACHINE kit (Ambion, Austin, TX) according to the manufac-
turer's instructions. Oocytes were surgically harvested from adult fe-
male Xenopus laevis, isolated by collagenase digestion, and microin-
jected with cRNA (25 ng/25 nl oocyte) [28,29]. After 24 h in culture to 
allow expression of the injected cRNAs, microinjected oocytes were 
radiolabeled with 45Ca2+ and agonist-triggered 45Ca2+ efflux was 
measured [28,29]. 
3. Results and discussion 
We recently observed that SIP and SPC activated SRE-
driven transcription via signaling pathways similar to those 
used by LPA receptors [24]. As lysosphingolipids and LPA 
are also similar in chemical structure, we hypothesized that 
their receptors might share close sequence homology. Accord-
ingly, the sequence of the recently characterized human LPA 
receptor Edg2 [23] was used to search the GenBank database 
for related sequences. Most related to Edg2 was human Edg4, 
with 46% identity at the amino acid level. Edg4 was recently 
shown to be an LPA receptor analogous functionally to Edg2 
[23,24]. Somewhat less homologous to Edg2 was a set of re-
lated orphan receptors: human Edgl [25], rat H218 [26], and 
human Edg3. Edgl, H218, and Edg3 share 31-34% amino 
acid sequence identity with Edg2, but 45-60% identity with 
each other (Fig. 1). These receptors also share the unusual 
feature of lacking the cysteine in extracellular loop 1 common 
among most other GPCRs. These observations suggested that 
Edgl, H218, and Edg3 might form a subfamily of GPCRs 
related to, but distinct from, the LPA receptors. 
To test the hypothesis that Edgl, H218, and Edg3 might be 
receptors for lysosphingolipids, we expressed these recombi-
nant receptors in Jurkat cells and Xenopus oocytes and sought 
lysosphingolipid-induced responses. When co-transfected with 
the SRE-luciferase reporter gene in Jurkat cells, H218 and 
Edg3 mediated significant increases in SRE-driven luciferase 
expression in response to 1 uM SP, dh-SP, SIP, dh-SIP and 
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Fig. 1. Alignment of amino acid sequences of human Edg3 (upper) with human Edgl (middle) and rat H218 (lower) proteins. To achieve maxi-
mal homology, gaps (represented by hyphens) are introduced. Asterisks indicate identical residues conserved in all three proteins. The putative 
transmembrane domains are overlined and labeled as TMl through TM7. 
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Fig. 2. Lysosphingolipid-induced activation of SRE-driven luciferase 
expression in transfected Jurkat T cells. A: Specificity of lysosphin-
golipid-induced responses. Jurkat cells co-transfected with SRE re-
porter gene plasmid and either empty pCDEF3 vector, H218/EF3 
or Edg3/EF3 were treated with various lipids at 1 uM each. Data 
are plotted as fold increase over respective controls without agonist. 
Values are mean±S.E.M. (« = 4) of one representative experiment 
of three or more for each agonist. B: Concentration dependence of 
responses to SIP. Values are the average of duplicates from a repre-
sentative of four different experiments. 
variety of mammalian cell types [3,7,11-13]. Attempts to eval-
uate the ability of transfected receptors to mediate Ca2+ sig-
naling were confounded by signaling in the untransfected 
cells. These background responses are presumably mediated 
by endogenous lysosphingolipid receptors in many mammali-
an cells. We therefore expressed the candidate receptors in 
Xenopus oocytes and assessed lysosphingolipid-triggered 
45Ca2+ efflux, which reflects increases in cytoplasmic Ca2+ in 
these cells. 
SIP and dh-SIP did not evoke responses in uninjected or 
control cRNA-injected oocytes (Fig. 3). By contrast, in oo-
cytes injected with cRNA encoding H218 or Edg3, 1 uM SIP 
and dh-SIP evoked significant increases in 45Ca2+ efflux (Fig. 
3A). Similar to results of the SRE reporter assay, dh-SIP had 
a less potent effect than SIP in the 45Ca2+ efflux assay. The 
structurally related lipids, ceramide, psychosine, SP and dh-
SP, all at 1 uM, were without effect (Fig. 3A). Concentration-
dependence studies of SIP showed that EC50 values were ap-
proximately 30 nM for both H218 and Edg3 receptors (Fig. 
3B). Oocytes injected with cRNA encoding human Edgl did 
not manifest significant increases in 45Ca2+ efflux in response 
to SIP or dh-SIP (data not shown). Tests of SPC- and LPA-
evoked signals were uninformative in the oocyte system due to 
inconsistent responses to SPC and high background response 
to LPA by uninjected oocytes, respectively. 
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SPC (Fig. 2A). The order of agonist activity at 1 |xM was 
SIP > S P C > S P > dh-SIP >dh-SP for both H218- and 
Edg3-transfected cells. This rank order is similar to previous 
determinations of rank order of activity of these sphingolipids 
on fibroblast mitogenesis and AP-1 transcriptional activation 
[6]. Other structurally related lipids C6-ceramide, psychosine 
(Fig. 2A) and LPA (data not shown) failed to elicit significant 
responses. Jurkat cells transfected with Edgl/EF3 showed 
only marginal activation of 1.74 ±0.07- and 1.68 ± 0.08-fold 
(meantS.E.M., « = 4) in response to 1 uM SIP and SPC, 
respectively. Jurkat cells transfected with the control pCDEF3 
vector did not show any significant increases in response to 
the lipids tested (Fig. 2A). 
SIP-induced SRE activation was significant at 1 nM SIP, 
reached a maximum at 100 nM, and exhibited EC50 values of 
approximately 5 nM for H218 and 10 nM for Edg3 (Fig. 2B). 
SPC mimicked the effect of SIP, but with EC50 values one 
order of magnitude higher at approximately 50 nM and 100 
nM for H218 and Edg3, respectively. 
It was known that lysosphingolipids elicited increases in 
cytoplasmic Ca2+ via a G protein-mediated mechanism in a 
B 
Edg3 
Concentration of S1P, log [M] 
Fig. 3. Lysosphingolipid-induced calcium mobilization by H218 and 
Edg3 heterologously expressed in Xenopus oocytes. A: Increases in 
45Ca2+ efflux from Xenopus oocytes in response to various sphingo-
lipids all at 300 nM final concentration. B: Concentration depend-
ence of response to SIP. Data (mean±S.E.M., « = 3) are expressed 
as fold increase over basal. These experiments were replicated at 
least twice. 
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Taken together with the results of the SRE reporter gene 
assay, these data strongly suggest that H218 and Edg3 are 
functional receptors for S I P and perhaps other related lyso-
sphingolipids. 
SP and dh-SP did not evoke increases in 4 5 Ca 2 + efflux from 
Xenopus oocytes, whereas they did activate SRE reporter gene 
in Jurkat cells. A possible explanation for this difference is the 
length of incubation times with lysosphingolipids in the two 
assays. The incubation time was 10 h in the SRE reporter 
gene assay and only 10 min in the 4 5 Ca 2 + efflux assay. It is 
likely that SP and dh-SP were converted to the active ligands 
S I P and dh-SIP by sphingosine kinases from Jurkat cells over 
10 h, but not in 10 min by Xenopus oocytes. These results of 
the two recombinant receptors are consistent with the pre-
vious demonstrat ion that mitogenic effects of SP in fibroblasts 
required its conversion to S I P [1]. 
SPC has been reported to desensitize cells to S IP and vice 
versa, suggesting that SPC may share a common receptor with 
S I P [14]. We observed that SPC elicited signals through both 
H218 and Edg3 receptors in the SRE reporter gene assay with 
EC50 one order of magnitude higher than SIP . Thus, these 
related bioactive lysosphingolipids can indeed act at the same 
receptors with different potency. 
The ligand for E d g l , the third orphan receptor in the group 
tested, remains unknown. It is possible that Edgl is indeed a 
receptor for one of the lipid ligands tested but couples to 
signaling pathways not assayed in this study [30]. Alterna-
tively, it is possible that Edgl mediates responses to a distinct 
ligand. 
S I P and SPC can elicit a variety of intracellular signaling 
events including mobilization of intracellular C a 2 + , and acti-
vation of pathways involving Gi-Ras-Raf-ERK and R h o 
GTPases [1,3,8,15]. The present study suggests that H218 
and Edg3 can mediate at least two signaling responses: 
C a 2 + mobilization, and SRE-driven transcription which re-
quires activation of bo th G;-Ras-Raf-ERK and R h o GTPases 
[27]. Whether these and other signaling responses to lyso-
sphingolipids are mediated by a single or multiple receptors 
in a given cell type is unknown. More importantly, the in vivo 
physiological and pathological functions of lysosphingolipid 
signaling remain to be explored. Identification of H218 and 
Edg3 as lysosphingolipid receptors provides new tools for 
defining the mechanisms of lysosphingolipid signaling and 
their physiological functions. 
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